Astrotech Corp

Análisis de la acción Astrotech Corp (ASTC)

$5.200

-0.701 (-13.48%)Al cierre

Loading chart…
Máximo
5.920
Apertura
5.870
Precio medio ponderado por volumen
5.33
Volumen
106.76K
Capitalización
15.81M
Mínimo
4.860
Importe
568.66K
EV/EBITDA, TTM
0.00

Astrotech Corporation is a spectrometry company, commercializing the Astrotech Mass Spectrometer Technology platform (AMS Technology). The Company's business units include Astrotech Technologies, Inc., 1st Detect Corporation, AgLAB, Inc., BreathTech Corporation, Pro-Control, Inc., and EN-SCAN, Inc. Astrotech Technologies, Inc. owns and licenses the intellectual property related to AMS Technology. 1st Detect Corporation is a manufacturer of explosives trace detectors and narcotics trace detectors developed for use in security and detection at airports, cargo hubs, military bases, law enforcement centers, and others. AgLAB, Inc. develops a series of mass spectrometers for use in the hemp and cannabis market with initial focus on optimizing yields in the distillation processes. BreathTech Corporation is developing a breath analysis tool to screen for volatile organic compound metabolites. Pro-Control, Inc. is focused on applying AMS Technology in industrial process control applications.

Análisis de IA of Astrotech Corp (ASTC)

Vender

Astrotech Corp is not a good buy right now due to its negative financial performance and high risk factors. The current price is $6.81, with an RSI of 38.64 indicating oversold conditions. However, the forward P/E ratio is 10.21, which suggests potential undervaluation, but the company has been burning cash at a rate of $14.9 million annually with only $1.05 million in revenue, leading to severe liquidity concerns.

Métricas de valoración

El PER previsto actual de Astrotech Corp (ASTC) es 10.21, frente a su media de 5 años de 1.36.

PER previsto

Muy sobrevalorado
Media 5A P/E
1.36
P/E actual
10.21
Sobrevalorada
4.79
Infravalorada
-2.07

EV/EBITDA previsto

Muy infravalorado
Media 5A EV/EBITDA
0.00
EV/EBITDA actual
0.00
Sobrevalorada
0.00
Infravalorada
0.00

Precio/ventas previsto

Infravalorado
Media 5A P/S
7.16
P/S actual
0.00
Sobrevalorada
10.77
Infravalorada
3.54

Escenarios de precio de Alphio AI para ASTC

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%ASTC

$4.99

Precio del escenario

B

Base

Base · 50%ASTC

$4.92

Precio del escenario

B

Bajista

Bajista · 25%ASTC

$4.51

Precio del escenario

Cronología de eventos

2026-09-25 (ET)

16:30:00

Major Averages Rise as Oil Prices Retreat

13:00:00

Major Averages Rise as Oil Prices Retreat

08:30:00

Astrotech Reports FY26 Revenue of $913,000

2026-07-22 (ET)

09:00:00

Astrotech Expands Board to Six Directors

2026-06-30 (ET)

09:00:00

Astrotech Submits $20M Proposal to NASA

Noticias

Preguntas frecuentes sobre ASTC, respondidas por Alphio AI

Astrotech Corporation is a spectrometry company, commercializing the Astrotech Mass Spectrometer Technology platform (AMS Technology). The Company's business units include Astrotech Technologies, Inc., 1st Detect Corporation, AgLAB, Inc., BreathTech Corporation, Pro-Control, Inc., and EN-SCAN, Inc. Astrotech Technologies, Inc. owns and licenses the intellectual property related to AMS Technology. 1st Detect Corporation is a manufacturer of explosives trace detectors and narcotics trace detectors developed for use in security and detection at airports, cargo hubs, military bases, law enforcement centers, and others. AgLAB, Inc. develops a series of mass spectrometers for use in the hemp and cannabis market with initial focus on optimizing yields in the distillation processes. BreathTech Corporation is developing a breath analysis tool to screen for volatile organic compound metabolites. Pro-Control, Inc. is focused on applying AMS Technology in industrial process control applications. It operates in the Technology sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Astrotech Corp is not a good buy right now due to its negative financial performance and high risk factors. The current price is $6.81, with an RSI of 38.64 indicating oversold conditions. However, the forward P/E ratio is 10.21, which suggests potential undervaluation, but the company has been burning cash at a rate of $14.9 million annually with only $1.05 million in revenue, leading to severe liquidity concerns.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar